drugset / Trial / NCT05809297

Diode Laser and Photodynamic Therapy Vs. Ciclopirox.

NCT05809297

Phase 4 Unknown 26 enrolled Universidad Complutense de Madrid
RandomizedParallel-groupSingle-blindTreatment

Summary

The main objective of this study is to compare the efficacy of treatment of onychomycosis by: diode laser combined with photodynamic therapy, and topical treatment with Ciclopirox Hydroxypropyl Chitosan (HPCH) Nail Lacquer. The study is a low-intervention, randomised controlled clinical trial. Patient recruitment will be done by including in the sample those patients who have diagnostic confirmation of onychomycosis in the Chiropodology and Surgery Service of the University Podiatry Clinic of the Complutense University of Madrid. Participants in the trial will be assigned with equal probability to each treatment arm, according to their consecutive inclusion in the study. Subsequently, treatment assignment will be determined by a random code. The treatment used will be evident to both the participant and the podiatrist responsible for the intervention. Visits will be made every 7 days at the start of treatment and for 9 weeks in group 1 (treatment with laser and photodynamic therapy), and monthly visits in group 2 (treatment with ciclopirox nail polish) during the 12 months of follow-up. Regardless of the follow-up week at which healing occurs, all patients will be reviewed at 3, 6, 9 and 12 months after the first visit.

Timeline

Start
2023-09-01
Primary completion
2024-04-01
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ciclopirox Unknown 8 % Topical

Indications